AKAP-Lbc mobilizes a cardiac hypertrophy signaling pathway.

Elevated catecholamines in the heart evoke transcriptional activation of the Myocyte Enhancer Factor (MEF) pathway to induce a cellular response known as pathological myocardial hypertrophy. We have discovered that the A-Kinase Anchoring Protein (AKAP)-Lbc is upregulated in hypertrophic cardiomyocytes. It coordinates activation and movement of signaling proteins that initiate MEF2-mediated ...
transcriptional reprogramming events. Live-cell imaging, fluorescent kinase activity reporters, and RNA interference techniques show that AKAP-Lbc couples activation of protein kinase D (PKD) with the phosphorylation-dependent nuclear export of the class II histone deacetylase HDAC5. These studies uncover a role for AKAP-Lbc in which increased expression of the anchoring protein selectively amplifies a signaling pathway that drives cardiac myocytes toward a pathophysiological outcome.
Mesh Terms:
14-3-3 Proteins, A Kinase Anchor Proteins, Active Transport, Cell Nucleus, Animals, COS Cells, Cardiomegaly, Cell Line, Cercopithecus aethiops, Cyclic AMP-Dependent Protein Kinases, Gene Expression Regulation, Guanine Nucleotide Exchange Factors, Heart Ventricles, Histone Deacetylases, Humans, Models, Biological, Myocytes, Cardiac, Myogenic Regulatory Factors, Phenylephrine, Phosphorylation, Protein Kinase C, Proto-Oncogene Proteins, RNA Interference, Rats, Signal Transduction
Mol. Cell
Date: Oct. 24, 2008
Download Curated Data For This Publication
105742
Switch View:
  • Interactions 1